Sign up
Quantellect · Congress · Trade Detail
NYSE: PFEPfizer Inc
RepublicanHouse

James B. Renacci sold Pfizer Inc (NYSE: PFE)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 6 trades in Pfizer Inc (PFE) since 2014, 3 purchases and 3 sales, worth an estimated $97K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of Pfizer Inc (NYSE: PFE) on January 11, 2016. Since that trade, PFE is up +35.72% against the S&P 500 up +349.25%, an outperformance of -313.53%.

Across these filings, James B. Renacci has been a balanced trader of PFE (a buy-to-sell ratio of 1.00). The most recent disclosed PFE transaction shown was dated September 19, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PFE trades
6
Disclosed Vol
$97K
Buys
3
50%
Sells
3
50%
Buy / Sell
1.00
ratio
First → Last
2014–2018

James B. Renacci's PFE trades vs the price

PFE is up +35.72% since James B. Renacci sold on January 11, 2016, versus +349.25% for the S&P 500.

Performance since this trade

Price change since trade
+35.72%
S&P 500 change since trade
+349.25%
Outperformance vs S&P 500
-313.53%

All James B. Renacci PFE trades

TradedTypeSizeReturnEst. profit
September 19, 2018SELL$28.60-12.08%
September 6, 2017SELL$21.67+16.06%
January 26, 2017BUY$19.36+29.89%-$2K
January 11, 2016SELL$18.53+35.72%
January 14, 2015BUY$18.75+34.16%-$2K
October 23, 2014BUY$16.37+53.68%-$4K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & PFE trading FAQ

Is it legal for James B. Renacci to trade Pfizer Inc (PFE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Pfizer Inc (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci sell PFE?

James B. Renacci disclosed a sale of $1,000 - $15,000 of Pfizer Inc (PFE) on January 11, 2016, according to public STOCK Act filings.

How has PFE performed since James B. Renacci's trade?

Since James B. Renacci sold PFE on January 11, 2016, the stock is up +35.72%, versus +349.25% for the S&P 500 over the same period, an outperformance of -313.53%.

How many times has James B. Renacci traded PFE?

James B. Renacci has disclosed 6 PFE trades since 2014 (3 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PFE trades?

Quantellect tracks every disclosed congressional trade in Pfizer Inc (PFE) on the Pfizer Inc congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's PFE tradesAll congressional filings for Pfizer IncJames B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.